Aziza Jurabekova

Aziza Jurabekova

Auto-generated profile, based on publicly available information

Aziza Jurabekova

Nazar Medical Eye Clinic, Tashkent, Uzbekistan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Data in Brief
Verified
Journal Article
Open access
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
FBFazilat Bakhritdinova
Fazilat Bakhritdinova
INIroda Nabieva
Iroda Nabieva
AJAziza Jurabekova
Aziza Jurabekova
This paper presents a data from examinations of patients treated in clinic of Tashkent medical academy, Uzbekistan. 165 Patients (305 eyes) with NPDR were randomly allocated to receive standard treatment as the control group, in addition to the standard treatment daily tablets of EGb 761 (Tanakan, Beaufour Ipsen Industrie, Paris, France) 120 mg as the 1st main group, or daily endonasal electrophoresis of Tanakan 40 mg as 2nd main group, within 10 days. All of the patients underwent baseline ophthalmologic examinations, definition of biochemical parameters of the lacrimal fluid and Doppler ultrasound imaging of the eye. Moreover, correlation between tear fluid and hemodynamics was calculated. This data is essential for researchers to develop diagnostic criteria for diabetic retinopathy stages. Data are also beneficial to practitioners in determining the diabetic retinopathy severity and choosing appropriate treatment.